Shreem Bio-Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 19-12-2024
- Paid Up Capital ₹ 5.00 M
as on 19-12-2024
- Company Age 11 Year, 29 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.00 M
as on 19-12-2024
- Revenue -9.55%
(FY 2020)
- Profit -27.99%
(FY 2020)
- Ebitda -15.38%
(FY 2020)
- Net Worth 17.91%
(FY 2020)
- Total Assets -30.92%
(FY 2020)
About Shreem Bio-Sciences
The Corporate was formerly known as Nmrps Pharma Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.00 M.
Rahul Choksi and Chaitali Choksi serve as directors at the Company.
- CIN/LLPIN
U24230GJ2013PTC077632
- Company No.
077632
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2013
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shreem Bio-Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Choksi  | Director | 26-Nov-2013 | Current |
| Chaitali Choksi | Director | 01-Aug-2018 | Current |
Financial Performance of Shreem Bio-Sciences.
Shreem Bio-Sciences Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 9.55% decrease. The company also saw a substantial fall in profitability, with a 27.99% decrease in profit. The company's net worth Soared by an impressive increase of 17.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shreem Bio-Sciences?
In 2020, Shreem Bio-Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Spinta Global Accelerator India Private LimitedActive 11 years 8 months
Rahul Choksi and Chaitali Choksi are mutual person
- Surya Choice Energy Private LimitedActive 12 years 3 months
Rahul Choksi and Chaitali Choksi are mutual person
- Shreem Spacebuild Infracon Private LimitedActive 9 years 11 months
Rahul Choksi and Chaitali Choksi are mutual person
- Shreem Professional Advisory Private LimitedActive 10 years 1 month
Rahul Choksi and Chaitali Choksi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 29 Jan 2018 | ₹1.00 M | Open |
How Many Employees Work at Shreem Bio-Sciences?
Unlock and access historical data on people associated with Shreem Bio-Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shreem Bio-Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreem Bio-Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
